Delivery Order SPE2DB22D1202-SPE2DB25FVFA5
- Not listed
- This is a $12,708.92 firm fixed-price delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency Troop Support Medical. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support military healthcare programs. The contract has an ultimate completion date of January 22, 2024 and was awarded on January 19, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $7,627.38 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 60S, a combination inhalation powder used in the treatment of chronic obstructive pulmonary disease. The award, issued on July 18, 2025, with an ultimate completion date of July 21, 2025, represents a firm fixed price delivery order with no set-aside designation. This contract was competitively awarded and will be performed at the vendor's corporate office...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,509.95, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 held by AmerisourceBergen with the Defense Logistics Agency Troop Support Medical, which...
- This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,070.66, is for the delivery of 4567254800 units of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for respiratory conditions. The contract has an ultimate completion date of February 13, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The contract, valued at $3,736.05, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication. The delivery order has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta (100-62.5-25) inhalation product. The order is valued at $3,922.33 and has an ultimate completion date of September 6, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- The U.S. Defense Logistics Agency (DLA) awarded a $36,100.70 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide TRELEGY ELLIPTA 200-62.5-25 60S respiratory medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, valued at up to $999,999,999 through December 2025, for supplying a wide range of medical commodities to support military treatment programs...
- This is a $21,548.51 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TRELEGY ELLIPTA 200-62.5-25 60S medication. The contract is not set aside and has an ultimate completion date of May 23, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a $17,507.31 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a respiratory medication, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This is a $14,938.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to supply TRELEGY ELLIPTA 200-62.5-25 60S medication. The order is not set aside for any small business designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a wide...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB25FVFA5Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,372.13 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination respiratory medication containing 60 doses. This competitively awarded, firm fixed-price delivery order was issued on July 18, 2025, with an ultimate completion date of July 21, 2025. The contract involves no set-aside designation and will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceuticals and medical supplies to military healthcare systems worldwide. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen fulfills orders across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and medical supplies for customers including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents a routine pharmaceutical resupply transaction within this broader strategic partnership supporting Department of Defense medical readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/18/25 |